Georgia Cancer Specialists

Marietta, Georgia 30341

0 studies enrolling now · 5 studies all time

What they study most

B-Cell Lymphoma, Breast Cancer, Chemonaive, ER Positive, Her2 Negative Breast Cancer Patients, Extensive Stage Lung Cancer, Follicular Lymphoma, Marginal Lymphoma, Non Squamous Lung Cancer, Small Cell Lung Cancer, Triple Negative Breast Cancer Patients

Studies at this site

• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung — Completed
• Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer — Completed
• A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer — Completed
• VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma — Completed